Drug Shortage Report for ORENCIA
| Report ID | 146256 |
| Drug Identification Number | 02402475 |
| Brand name | ORENCIA |
| Common or Proper name | Abatacept |
| Company Name | BRISTOL-MYERS SQUIBB CANADA |
| Market Status | MARKETED |
| Active Ingredient(s) | ABATACEPT |
| Strength(s) | 125MG |
| Dosage form(s) | SOLUTION |
| Route of administration | SUBCUTANEOUS SUBCUTANEOUS |
| Packaging size | 4 x 1mL |
| ATC code | L04AA |
| ATC description | IMMUNOSUPPRESSANTS |
| Reason for shortage | Delay in shipping of the drug. |
| Anticipated start date | 2021-09-27 |
| Actual start date | 2021-09-27 |
| Estimated end date | 2021-10-31 |
| Actual end date | 2021-10-13 |
| Shortage status | Resolved |
| Updated date | 2021-10-14 |
| Company comments | Allocation will be based on historical demand. |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 2344 BOUL. ALFRED-NOBEL, SUITE 300 ST-LAURENT, QUEBEC CANADA H4S 0A4 |
| Company contact information | For more information please contact the Customer Service Desk at 1-800-267-0005 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v6 | 2021-10-14 | English | Compare |
| v5 | 2021-10-13 | French | Compare |
| v4 | 2021-10-13 | English | Compare |
| v3 | 2021-09-28 | English | Compare |
| v2 | 2021-09-27 | French | Compare |
| v1 | 2021-09-27 | English | Compare |
Showing 1 to 6 of 6